![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/valuestock_image_866.jpeg)
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 13.94% on an annualized basis producing an average annual return of 27.26%. Currently, Novavax has a market capitalization of $4.14 billion.
Buying $100 In NVAX: If an investor had bought $100 of NVAX stock 5 years ago, it would be worth $327.62 today based on a price of $54.33 for NVAX at the time of writing.
Novavax's Performance Over Last 5 Years
![](https://www.benzinga.com/files/images/story/2022/1650380453_0.png)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.